Beigene Stock Filter Stocks by Fundamentals
BGNE Stock | USD 156.39 1.31 0.84% |
BeiGene fundamentals help investors to digest information that contributes to BeiGene's financial success or failures. It also enables traders to predict the movement of BeiGene Stock. The fundamental analysis module provides a way to measure BeiGene's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BeiGene stock.
BeiGene | Number of Shares Shorted |
BeiGene Number of Shares Shorted Analysis
2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 990.9M | 1.3B | 3.2B | 3.4B | Cost Of Revenue | 1.6B | 1.9B | 463.9M | 755.2M |
BeiGene Number of Shares Shorted Driver Correlations
Understanding the fundamental principles of building solid financial models for BeiGene is extremely important. It helps to project a fair market value of BeiGene Stock properly, considering its historical fundamentals such as Number of Shares Shorted. Since BeiGene's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of BeiGene's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of BeiGene's interrelated accounts and indicators.
Click cells to compare fundamentals
Competition |
Based on the recorded statements, BeiGene has 0.0null of outstending shares currently sold short by investors. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Number of Shares Shorted (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Efficient Frontier Now
Efficient FrontierPlot and analyze your portfolio and positions against risk-return landscape of the market. |
All Next | Launch Module |
BeiGene Fundamentals
Return On Equity | -0.22 | ||||
Return On Asset | -0.12 | ||||
Profit Margin | (0.36) % | ||||
Operating Margin | (0.61) % | ||||
Current Valuation | 14.55 B | ||||
Shares Outstanding | 104.43 M | ||||
Shares Owned By Insiders | 19.84 % | ||||
Shares Owned By Institutions | 48.17 % | ||||
Number Of Shares Shorted | 1.73 M | ||||
Price To Earning | (16.19) X | ||||
Price To Book | 4.57 X | ||||
Price To Sales | 6.90 X | ||||
Revenue | 2.46 B | ||||
Gross Profit | (511.06 M) | ||||
EBITDA | (1.12 B) | ||||
Net Income | (881.71 M) | ||||
Cash And Equivalents | 5.7 B | ||||
Cash Per Share | 55.17 X | ||||
Total Debt | 930.18 M | ||||
Debt To Equity | 0.12 % | ||||
Current Ratio | 4.54 X | ||||
Book Value Per Share | 33.83 X | ||||
Cash Flow From Operations | (1.16 B) | ||||
Short Ratio | 6.13 X | ||||
Earnings Per Share | (8.45) X | ||||
Target Price | 275.27 | ||||
Number Of Employees | 10.6 K | ||||
Beta | 0.62 | ||||
Market Capitalization | 16.97 B | ||||
Total Asset | 5.81 B | ||||
Retained Earnings | (7.96 B) | ||||
Working Capital | 2.39 B | ||||
Current Asset | 106.27 M | ||||
Current Liabilities | 35.17 M | ||||
Z Score | 9.31 | ||||
Net Asset | 5.81 B |
About BeiGene Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BeiGene's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BeiGene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BeiGene based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. BeiGene, Ltd. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts. Beigene operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 8600 people.
Pair Trading with BeiGene
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BeiGene position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BeiGene will appreciate offsetting losses from the drop in the long position's value.Moving together with BeiGene Stock
0.66 | MBRX | Moleculin Biotech Financial Report 9th of May 2024 | PairCorr |
Moving against BeiGene Stock
0.56 | CLVRW | Clever Leaves Holdings | PairCorr |
0.54 | MGNX | MacroGenics Financial Report 14th of May 2024 | PairCorr |
The ability to find closely correlated positions to BeiGene could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BeiGene when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BeiGene - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BeiGene to buy it.
The correlation of BeiGene is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BeiGene moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BeiGene moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BeiGene can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out BeiGene Piotroski F Score and BeiGene Altman Z Score analysis. For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Complementary Tools for BeiGene Stock analysis
When running BeiGene's price analysis, check to measure BeiGene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BeiGene is operating at the current time. Most of BeiGene's value examination focuses on studying past and present price action to predict the probability of BeiGene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BeiGene's price. Additionally, you may evaluate how the addition of BeiGene to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Transaction History View history of all your transactions and understand their impact on performance | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities |
Is BeiGene's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BeiGene. If investors know BeiGene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BeiGene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (8.45) | Revenue Per Share 23.554 | Quarterly Revenue Growth 0.669 | Return On Assets (0.12) | Return On Equity (0.22) |
The market value of BeiGene is measured differently than its book value, which is the value of BeiGene that is recorded on the company's balance sheet. Investors also form their own opinion of BeiGene's value that differs from its market value or its book value, called intrinsic value, which is BeiGene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BeiGene's market value can be influenced by many factors that don't directly affect BeiGene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BeiGene's value and its price as these two are different measures arrived at by different means. Investors typically determine if BeiGene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BeiGene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.